Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-001872
Filing Date
2022-02-24
Accepted
2022-02-24 16:46:43
Documents
2
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4105
2 TBURESPOA tburespoa.txt EX-24 3314
  Complete submission text file 0001562180-22-001872.txt   8907
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Bures Thomas (Reporting) CIK: 0001787029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 22671889